Results 21 to 30 of about 36,244 (312)

First Report of Cerebral Venous Thrombosis Following Inactivated-Virus Covid Vaccination (Sinopharm and Sinovac)

open access: yesJournal of Stroke and Cerebrovascular Diseases, 2022
Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines.
Sajid Hameed   +2 more
exaly   +1 more source

Evaluation of Antibody Response in Patients with Cancer Following Sinopharm Covid-19 Vaccine in 2021 [PDF]

open access: yesJournal of Mazandaran University of Medical Sciences
Background and purpose: COVID-19 is one of the biggest pathogens that mainly targets the human respiratory system. Among the preventive methods against contracting COVID-19, vaccination has had an important effect in preventing COVID-19 and is an ...
Mohammad Eslamijouybari   +4 more
doaj   +1 more source

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists

open access: yesJournal of Diabetes Research, 2022
The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes.
Rui Song   +12 more
doaj   +1 more source

Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes

open access: yesJournal of Diabetes Research, 2023
Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disease that has become a growing health problem worldwide, and the dangers of hyperglycemia and its chronic complications have long been considered a goal of diabetes treatment.
Zijun Ma   +4 more
doaj   +1 more source

Correction: Unexpected hypereosinophilia after sinopharm vaccination: a case report

open access: yesBMC Infectious Diseases
Behnam Dalfardi   +5 more
openaire   +3 more sources

Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy

open access: yesHuman Vaccines & Immunotherapeutics, 2023
The rising need for repeated booster vaccinations against SARS-CoV-2 infections raises the question of whether chronic immunosuppressive chemotherapies influence the efficacy of vaccination. Here, we present the case of a 70-year-old post-thymoma surgery
Akos Koller, János Szebeni
doaj   +1 more source

Post COVID-19 vaccination Guillain-Barre syndrome: three cases

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of patients, it is preceded by an upper respiratory or gastrointestinal tract infection.
Seyedehnarges Tabatabaee   +6 more
doaj   +1 more source

Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study. [PDF]

open access: yesBMC Public Health
Although the safety of the BBIBP-CorV (Sinopharm) vaccine has been confirmed in both adults and children, safety data remain limited for individuals under 18 years of age.
Emamian MH   +13 more
europepmc   +2 more sources

Vaccine Induced Immune Thrombotic Thrombocytopenia After Sinopharm Vaccination: A Systematic Review of Case Reports. [PDF]

open access: yesClin Case Rep
Vaccine‐induced thrombotic thrombocytopenia (VITT) has been linked to vector‐based vaccines, but only four cases following whole‐virus vaccines (Sinopharm) have been reported, as far as we are aware.
Rehman S   +5 more
europepmc   +2 more sources

Impact of previous infection and body mass index on interferon-gamma and immunoglobulin G level generated against three types of vaccines available in Iraq

open access: yesBiomedical and Biotechnology Research Journal, 2022
Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj   +1 more source

Home - About - Disclaimer - Privacy